The Effect of Preoperative Metformin on Postoperative Hyperglycemia in Non-Diabetic Patients: A Randomized Clinical Trial
-
Arash Peyvandi Yazdi
,
Ebrahim Golmakani
,
Veghar Hejazi
,
Andia Peivandi Yazdi
,
Mehryar Taghavi Gilani
Abstract
Background: Blood glucose control during surgery can decrease the infection, disability, and death rate. The purpose of this study was to determine the effect of preoperative metformin on blood glucose levels in nondiabetic orthopedic surgery.
Methods: This clinical trial was conducted on 176 nondiabetic patients with ASA class I or II who were candidates for orthopedic surgery. The patients were randomly divided into two equal groups. The metformin group received 500 mg metformin tablet orally and the placebo group received placebo tablet 30 minutes before the surgery. Blood glucose was measured every 6-hour to 24 hours and blood urine nitrogen (BUN), creatinine was measured preoperatively and the day after surgery. The data was analyzed by SPSS v21 and P value<0.05 was significant.
Results: Demographic characteristics such as age, sex and body mass index (BMI) had no significant difference in two groups. Creatinine and BUN were similar in two groups. Preoperative blood glucose was 101.8±22.6 mg/dl in the metformin group and 109.7±24.8 mg/dl in the control group without significant difference (p=0.08). However, BS at hours 6, 12, showed a significant difference between the two groups (p<0.001, 0.022) and then blood glucose was similar in two groups (0.8, 0.12 respectively).
Conclusion: Preoperative metformin (500 mg) was effective for blood glucose control in nondiabetic patients undergoing orthopedic surgery. However, additional research is required to determine the efficacy of this therapy.
[2] Dolphin AC. Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond. Nat Rev Neurosci. 2012; 13(8):542-55.
[3] Bannister CA, Holden SE, Jenkins‐Jones S, Morgan CL, Halcox JP, Schernthaner G, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls. Diabetes Obes Metab. 2014; 16(11):1165-73.
[4] Anisimov VN, Berstein LM, Popovich IG, Zabezhinski MA, Egormin PA, Piskunova TS, et al. If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany NY). 2011; 3(2):148-57.
[5] Farrokhi F, Smiley D, Umpierrez GE. Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab. 2011; 25(5):813–824.
[6] McMahon M, Gerich J, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev. 1988; 4(1):17-30.
[7] Shamoon H, Hendler R, Sherwin RS. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab. 1981; 52(6):1235-41.
[8] Ghods K, Davari H, Ebrahimian A. Evaluation of the effect of metformin and insulin in hyperglycemia treatment after coronary artery bypass surgery in nondiabetic patients. Ann Card Anaesth. 2017; 20(4):427-31.
[9] Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005; 115(8):2277-86.
[10] Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. The Ann Thorac Surg. 1999; 67(2):352-60.
[11] Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, Williams BA, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005; 80(7):862-6.
[12] Davidson P, Kwiatkowski CA, Wien M. Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient. Nutr Clin Pract. 2015; 30(5):652-9.
[13] Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. N Engl J Med. 2008; 358(2):125-39.
[14] Seelig E, Meyer S, Timper K, Nigro N, Bally M, Pernicova I, et al. Metformin prevents metabolic side effects during systemic glucocorticoid treatment. Eur J Endocrinol. 2017; 176(3):349-58.
[15] Magalhães FO, Gouveia LM, Torquato MT, Paccola GM, Piccinato CE, Foss MC. Metformin increases blood flow and forearm glucose uptake in a group of non-obese type 2 diabetes patients. Horm Metab Res. 2006; 38(8):513-7.
[16] Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev. 2017; 40:31-44.
[17] Miles JM, Rule AD, Borlaug BA. Use of metformin in diseases of aging. Curr Diab Rep. 2014;14(6):490.
[18] Nasri H, Rafieian-Kopaei M. Metformin: current knowledge. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2014; 19(7):658.
[19] Chen K, Li Y, Guo Z, Zeng Y, Zhang W, Wang H. Metformin: current clinical applications in nondiabetic patients with cancer. Aging (Albany NY). 2020; 12(4):3993-4009.
[20] Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009; 15(5):469-74.
[21] Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, et al. The society of thoracic surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009; 87:663–9.
[22] Mojtahedzadeh M, Jafarieh A, Najafi A, Khajavi MR, Khalili N. Comparison of metformin and insulin in the control of hyperglycaemia in non-diabetic critically ill patients. Endokrynol Pol. 2012; 63:206–11.
[23] Azarfarin R, Sheikhzadeh D, Mirinazhad M, Bilehjani E, Alizadehasl A. Do nondiabetic patients undergoing coronary artery bypass grafting acta anaesthesiologica surgery require intraoperative management of hyperglycemia? Taiwanica. 2011; 49:41–5.
[24] Azarfarin R, Alizadeh-Asl A. Prevalence and intensity of hypoglycemia in non-diabetic patients undergoing coronery artery bypass graft surgery with and without cardiopulmonary bypass. Saudi Med J. 2008; 29:1294–8.
[25] Liao P, DeSantis AJ, Schmeltz LR, Schmidt K, O'Shea-Mahler E, Victor S, et al. Insulin resistance following cardiothoracic surgery in patients with and without a preoperative diagnosis of type 2 diabetes during treatment with intravenous insulin therapy for postoperative hyperglycemia. J Diabetes Complications. 2008; 22:229-34.
| Files | ||
| Issue | Vol 10 No Supp. 2 (2024): Supplement 2 |
|
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/aacc.v10is2.17218 | |
| Keywords | ||
| Metformin Nondiabetic patients Blood glucose | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
